A law firm is probing Hologic’s $76/share deal with Blackstone and TPG over shareholder fairness concerns.

The Ademi Firm is investigating Hologic Inc.'s proposed $76-per-share cash deal with Blackstone and TPG, including a contingent value right up to $3 per share tied to future revenue targets, over concerns the board may not have ensured fair treatment for shareholders. The probe focuses on whether fiduciary duties were met, especially regarding the transaction's terms, a penalty for competing bids, and generous change-of-control benefits for insiders. The firm, which specializes in shareholder litigation, is offering free consultations with no cost or obligation to affected investors.